Advertisement
RayBiotech
RayBiotech

The Scientist

» drug development, evolution and ecology

Most Recent

image: Down and Dirty

Down and Dirty

By | September 1, 2012

Diverse plant communities create a disease-fighting "soil genotype."

3 Comments

image: Good Vibrations

Good Vibrations

By | September 1, 2012

Researchers are learning how species from across the animal kingdom use seismic signals to mate, hunt, solve territorial disputes, and much more.

1 Comment

image: From Plants and Fungi to Clouds

From Plants and Fungi to Clouds

By | August 31, 2012

Salt compounds produced by plant and fungus species help form organic aerosols that form clouds and produce rain.

0 Comments

image: Stalking Sharks

Stalking Sharks

By | August 30, 2012

Researchers monitor the movement of the Pacific’s largest predators and share the information with the world in real time.

0 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Orphan Drugs Lucrative

Orphan Drugs Lucrative

By | August 24, 2012

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

1 Comment

image: Mothers-In-Law and Menopause

Mothers-In-Law and Menopause

By | August 23, 2012

Competition for resources between mothers- and daughters-in-law having children at the same time could have been a driver for the emergence of menopause.

3 Comments

image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.

3 Comments

image: Hope for Male Contraception

Hope for Male Contraception

By | August 16, 2012

A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.

0 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement